1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Scoping carbon dioxide removal options for Germany–What is their potential contribution to Net-Zero CO2?
(
- Contribution to journal › Article
-
Mark
Net-zero CO2 Germany - A retrospect from the year 2050
(
- Contribution to journal › Article
- 2015
-
Mark
Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo.
(
- Contribution to journal › Article
- 2013
-
Mark
A human icam-1 antibody isolated by a function-first approach has potent macrophage-dependent antimyeloma activity in vivo.
(
- Contribution to journal › Article
- 2009
-
Mark
Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions.
(
- Contribution to journal › Article